Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

VREX vs ESP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ESP Captures Overall Composite Edge (39.8 SELL vs 54.8 HOLD), While VREX Leads 3–2 on Growth & Valuation Pillars

ESP Overall Winner 6-Pillar Tally: VREX 3 – 2 ESP (1 Tie) Matrix Metrics: VREX 4 – 6 ESP

As of Nov 20, 2026, Espey Mfg. & Electronics Corp (ESP) captures the overall head-to-head institutional edge over Varex Imaging Corporation (VREX) on higher Unified Composite conviction (39.8/100 SELL vs. 54.8/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while VREX wins 3–2 across the 6-pillar growth and valuation breakdown. VREX trades at $18.10 (16.9x Forward P/E, 8.3% operating margin) versus ESP at $37.03 (10.0x Forward P/E, 24.4% operating margin).

  • Composite vs. Pillar Nuance: While VREX currently prints a higher short-term Unified Composite Score (54.8/100 HOLD vs. ESP 39.8/100 SELL), ESP captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (24.4% vs. 8.3% operating margin) and revenue trajectory (+16.7% vs. +3.7% YoY).
  • Technical & Structure Timing Caution: VREX is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 28.4); meanwhile ESP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VREX vs ESP
VREX NASDAQ
Varex Imaging Corporation Common Stock
Electronic Components, Nec
$18.10
-0.22% 1D
Market Cap $770.3M
TTM Revenue $865M
Forward P/E 16.9x
Beta / 30D Vol 0.65β · 5% Vol
Unified Composite Score
54.8 / 100 HOLD
Tech 46.0 Fund 45.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.3%) with fading momentum, RSI 28
RSI-14: 28.4 · SMA20: $18.34 · SMA50: $18.41
ESP NYSE American Head-to-Head Winner
Espey Mfg. & Electronics Corp
Electronic Components, Nec
$37.03
-5.05% 1D
Market Cap $112.2M
TTM Revenue $48M
Forward P/E 10.0x
Beta / 30D Vol 1.38β · 67% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 44.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.1%), weak momentum, RSI 22
RSI-14: 21.9 · SMA20: $47.62 · SMA50: $55.28

6-Pillar Scorecard Institutional Category Breakdown (VREX 3 – 2 ESP)

Columns: Metric · VREX · ESP
1. Valuation Multiples ESP
Forward P/E 16.9x 10.0x
Trailing P/E 34.2x 10.1x
PEG Ratio 6.30x N/M
EV / Revenue 0.9x 2.4x
2. Growth & Scale VREX
Revenue Growth (YoY) +3.7% +16.7%
Earnings Growth (YoY) +453.4% -1.3%
TTM Revenue (USD) $865M $48M
Market Cap $770.3M $112.2M
3. Profitability & Quality ESP
Gross Margin 34.3% 34.2%
Operating Margin 8.3% 24.4%
Net Profit Margin 2.6% 23.5%
Return on Equity (ROE) 4.6% 20.1%
4. Balance Sheet & Cash Flow VREX
Cash Generation (TTM) $100M EBITDA $4.4M
Cash Flow Margin 11.5% EBITDA Mgn 9.3%
Net Cash / Leverage $11.78 Book/Sh · 4.6% ROE $21.05 Book/Sh · 20.1% ROE
Dividend Yield None (0.00%) 2.43%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 112.0% (18th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat VREX
OpEx & R&D Intensity 26.0% of Rev ($225M) 9.8% of Rev ($4.7M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Medical Devices Operator Electrical Equipment & Parts Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VREX (4) vs ESP (6)
Institutional Metric VREX ESP Criterion Row Edge
Market Capitalization
Scale
$770.3M $112.2M Larger Scale VREX
Trailing P/E Ratio
Valuation
34.2x 10.1x Lower Multiple ESP
Forward P/E Ratio
Valuation
16.9x 10.0x Lower Multiple ESP
Revenue Growth (YoY)
Growth
+3.7% +16.7% Higher Growth ESP
Operating Margin (TTM)
Profitability
8.3% 24.4% Higher Margin ESP
Net Profit Margin
Profitability
2.6% 23.5% Higher Margin ESP
Return on Equity (ROE)
Capital Efficiency
4.6% 20.1% Higher ROE ESP
52-Week Range Position
Momentum
94% ($9–$19) 1% ($37–$75) Stronger Trend VREX
Beta / 30D Volatility
Risk Regime
0.65β · 5% Vol 1.38β · 67% Vol Lower Realized Risk VREX
Unified Institutional Score
Composite Signal
54.8 / 100 (HOLD) 39.8 / 100 (SELL) Higher Composite VREX
Trailing 12M Revenue (USD)
Operating Scale
$865M $48M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
34.3% 34.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
6.30x PEG · 0.9x EV/Rev N/M PEG · 2.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$100M EBITDA ($11.78 Book/Sh · 4.6% ROE) $4.4M ($21.05 Book/Sh · 20.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VREX +26.07 pp
VREX: -1.68% · ESP: -27.75%
3M Horizon VREX +39.03 pp
VREX: -2.27% · ESP: -41.3%
6M Horizon VREX +115.45 pp
VREX: +79.74% · ESP: -35.71%
1Y Horizon VREX +80.95 pp
VREX: +76.76% · ESP: -4.19%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VREX vs ESP. Trailing 12-month operating profitability (VREX 8.3% vs ESP 24.4%) and valuation multiples (VREX 16.9x vs ESP 10.0x Forward P/E) are benchmarked directly in Pillar 4 below.

VREX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$865M
Gross Margin34.3%
Op. Margin8.3%
ROE / Fwd P/E4.6% · 16.9x
ESP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$48M
Gross Margin34.2%
Op. Margin24.4%
ROE / Fwd P/E20.1% · 10.0x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VREX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 112.0%
IV Percentile 18th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VREX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ESP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ESP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VREX Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $770.3M market capitalization and 8.3% operating margin.
OpEx & R&D Reinvestment 26.0% of Rev ($225M)
90D Engineering Disclosures 0 Published
ESP Moat Profile Scale & Operating Efficiency Moat
Electrical Equipment & Parts Operator
Competes within the Electrical Equipment & Parts value chain with $112.2M market capitalization and 24.4% operating margin.
OpEx & R&D Reinvestment 9.8% of Rev ($4.7M)
90D Engineering Disclosures 0 Published

Investor FAQ VREX vs ESP Key Questions & Quantitative Answers

As of Nov 20, 2026, Espey Mfg. & Electronics Corp (ESP) captures the overall head-to-head institutional edge over Varex Imaging Corporation (VREX) on higher Unified Composite conviction (39.8/100 SELL vs. 54.8/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while VREX wins 3–2 across the 6-pillar growth and valuation breakdown. VREX trades at $18.10 (16.9x Forward P/E, 8.3% operating margin) versus ESP at $37.03 (10.0x Forward P/E, 24.4% operating margin). Composite vs. Pillar Nuance: While VREX currently prints a higher short-term Unified Composite Score (54.8/100 HOLD vs. ESP 39.8/100 SELL), ESP captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (24.4% vs. 8.3% operating margin) and revenue trajectory (+16.7% vs. +3.7% YoY). Technical & Structure Timing Caution: VREX is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 28.4); meanwhile ESP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VREX leads the Growth & Scale pillar: VREX posts +3.7% YoY revenue growth and +453.4% YoY earnings growth on $865M TTM revenue (34.3% gross margin, 8.3% operating margin), compared with ESP at +16.7% YoY revenue growth and -1.3% YoY earnings growth on $48M TTM revenue (34.2% gross margin, 24.4% operating margin). On trailing 12-month operating scale, VREX generates $865M in USD-normalized revenue versus $48M for ESP. In operating R&D and SG&A reinvestment, VREX deploys 26.0% of Rev ($225M) (0 90-day corporate R&D disclosures) versus 9.8% of Rev ($4.7M) (0 disclosures) for ESP.

ESP screens cheaper on headline valuation multiples. VREX trades at 16.9x Forward P/E, 34.2x Trailing P/E, 6.30x PEG, and 0.9x EV/Revenue (11.5% EBITDA margin), whereas ESP trades at 10.0x Forward P/E, 10.1x Trailing P/E, N/M PEG, and 2.4x EV/Revenue (9.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VREX (4.6% ROE) versus ESP (20.1% ROE) capital efficiency.

In options market volatility and institutional positioning, VREX carries 112.0% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.65β · 5% Vol realized risk). By comparison, ESP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.38β · 67% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.